At the end of the latest market close, Global Cord Blood Corporation (CO) was valued at $2.22. In that particular session, Stock kicked-off at the price of $2.29 while reaching the peak value of $2.315 and lowest value recorded on the day was $2.21. The stock current value is $2.91.Recently in News on August 16, 2022, Global Cord Blood Corporation Files Annual Report on Form 20-F. Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The filed Form 20-F includes audited financial statements for the fiscal year ended March 31, 2022. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission’s website at http://www.sec.gov and also be found at the Investor Relations section of GCBC’s website at http://ir.globalcordbloodcorp.com. You can read further details here
Global Cord Blood Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.50 on 02/15/22, with the lowest value was $2.03 for the same time period, recorded on 08/02/22.
Global Cord Blood Corporation (CO) full year performance was -51.74%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Global Cord Blood Corporation shares are logging -47.09% during the 52-week period from high price, and 43.35% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.03 and $5.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5016242 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Global Cord Blood Corporation (CO) recorded performance in the market was -47.02%, having the revenues showcasing -35.28% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 310.71M, as it employees total of 1202 workers.
Global Cord Blood Corporation (CO) in the eye of market guru’s
During the last month, 0 analysts gave the Global Cord Blood Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.60, with a change in the price was noted +0.48. In a similar fashion, Global Cord Blood Corporation posted a movement of +19.80% for the period of last 100 days, recording 213,512 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Global Cord Blood Corporation (CO): Stocks Technical analysis and Trends
Raw Stochastic average of Global Cord Blood Corporation in the period of last 50 days is set at 83.80%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 81.58%. In the last 20 days, the company’s Stochastic %K was 44.29% and its Stochastic %D was recorded 42.31%.
If we look into the earlier routines of Global Cord Blood Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -47.02%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -44.50%, alongside a downfall of -51.74% for the period of the last 12 months. The shares increased approximately by -12.60% in the 7-day charts and went down by -7.50% in the period of the last 30 days. Common stock shares were lifted by -35.28% during last recorded quarter.